Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22,338	3,657	1,812	2,732	9,189
Short-Term Investments	17,739	-	10,000	16,000	13,010
Cash & Short-Term Investments	40,077	3,657	11,812	18,732	22,199
Cash Growth	996.00%	-69.04%	-36.94%	-15.62%	15.53%
Accounts Receivable	2,325	247.21	446.21	1,277	7,628
Other Receivables	96.01	85.09	19.54	50.97	55.15
Receivables	2,421	332.3	465.75	1,671	8,825
Inventory	1,137	1,076	2,588	2,946	3,350
Prepaid Expenses	138.25	381.52	204.45	568.66	337.92
Other Current Assets	217.44	1,364	92.36	93.33	138.65
Total Current Assets	43,990	6,810	15,163	24,012	34,851
Property, Plant & Equipment	3,652	3,583	2,904	6,376	6,073
Long-Term Investments	29,720	22,732	1,593	1,469	4,930
Other Intangible Assets	52,170	33,170	31,170	33,175	33,664
Other Long-Term Assets	506.6	498.05	914.36	1,268	929.34
Total Assets	130,739	67,705	52,792	67,327	80,528
Accounts Payable	498.72	555.33	430.52	686.72	191.61
Accrued Expenses	144.72	137.19	141.71	141.35	123.66
Short-Term Debt	17,264	25,832	5,400	5,900	14,014
Current Portion of Long-Term Debt	-	-	-	111.08	833.32
Current Portion of Leases	448.86	440.49	114.1	196.17	354.1
Other Current Liabilities	1,164	521.41	860.43	1,957	1,744
Total Current Liabilities	19,521	27,487	6,947	8,992	17,261
Long-Term Debt	-	-	-	-	111.08
Long-Term Leases	70.44	320.53	32.43	41.7	174.69
Pension & Post-Retirement Benefits	-	-	-	-	57.13
Long-Term Deferred Tax Liabilities	-	-	-	-	1,296
Other Long-Term Liabilities	421.13	459.04	541.56	57.23	57.23
Total Liabilities	20,012	28,266	7,521	9,091	18,957
Common Stock	48,020	19,911	19,905	19,841	19,330
Additional Paid-In Capital	96,832	39,806	38,827	145,476	133,406
Retained Earnings	-41,851	-19,741	-12,812	-106,288	-90,481
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	7,729	-532.99	-645.72	-789.52	-680.57
Shareholders' Equity	110,726	39,438	45,271	58,235	61,571
Total Liabilities & Equity	130,739	67,705	52,792	67,327	80,528
Total Debt	17,784	26,593	5,547	6,249	15,488
Net Cash (Debt)	22,293	-22,937	6,265	12,483	6,712
Net Cash Growth	-	-	-49.81%	86.00%	-
Net Cash Per Share	0.21	-1.79	78.76	158.55	90.90
Filing Date Shares Outstanding	97.06	79.64	79.62	79.36	77.31
Total Common Shares Outstanding	97.06	79.64	79.62	79.36	77.31
Working Capital	24,469	-20,677	8,216	15,020	17,590
Book Value Per Share	1140.83	495.22	568.62	733.80	796.36
Tangible Book Value	58,556	6,269	14,101	25,061	27,906
Tangible Book Value Per Share	603.32	78.71	177.11	315.78	360.94
Land	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	3,834	5,190	5,190
Machinery	10,435	10,435	10,435	11,644	13,822
Construction In Progress	26.55	114.29	16	773.4	225

Source: S&P Global Market Intelligence. Standard template. Financial Sources.